Reviewed by PillSeek Editorial Team · Last updated
About This Medication
This medication is a Brown;orange Capsule 18 mm, Capsule with imprint "WATSON;3211". It contains Rivastigmine tartrate 6 mg; of Rivastigmine tartrate[rivastigmine];. This belongs to the Cholinesterase inhibitor pharmacologic class. It is manufactured by Actavis Pharma, Inc.. For details please contact your physician.
Basic Information
- Imprint
- WATSON;3211
- Color
- Brown;orange
- Shape
- Capsule
- Size
- 18 mm
Drug Information
- Strength
- Rivastigmine tartrate 6 mg;
- Dosage Form
- Capsule
- RxCUI
- 312836
Pharmaceutical Classification
- Pharmacologic Class
- Cholinesterase inhibitor
Related Medications
Other drugs in the same class: Cholinesterase Inhibitor
- AriceptDONEPEZIL HYDROCHLORIDE 10 mg;YELLOW • ROUND
- AriceptDONEPEZIL HYDROCHLORIDE 23 mg;RED • ROUND
- AriceptDONEPEZIL HYDROCHLORIDE 5 mg;WHITE • ROUND
- DonepezilDONEPEZIL HYDROCHLORIDE 10 mg;YELLOW • ROUND
- DonepezilDONEPEZIL HYDROCHLORIDE 5 mg;WHITE • ROUND
- donepezil hydrochloridedonepezil hydrochloride 10 mg;YELLOW • ROUND
- donepezil hydrochlorideDONEPEZIL HYDROCHLORIDE 10 mg;WHITE • ROUND
- donepezil hydrochlorideDONEPEZIL HYDROCHLORIDE 5 mg;BLUE • ROUND
- Donepezil hydrochlorideDONEPEZIL HYDROCHLORIDE 23 mg;RED • ROUND
- Donepezil HydrochlorideDONEPEZIL HYDROCHLORIDE 10 mg;YELLOW • ROUND
Ingredients
- Active Ingredients
- Rivastigmine tartrate[rivastigmine];
- Inactive Ingredients
- Silicon dioxide;hypromellose, unspecified;magnesium stearate;microcrystalline cellulose;gelatin;titanium dioxide;ferric oxide yellow;ferric oxide red;ferrosoferric oxide;d&c yellow no. 10;fd&c blue no. 1;fd&c blue no. 2;indigotindisulfonate sodium;fd&c red no. 40;shellac;
Additional Information
- Manufacturer
- Actavis Pharma, Inc.
- Status (Rx/OTC)
- Rx
Browse Related Pills
⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.